Henderson Michael Thomasinsider trades
In SEC Form 4 filings, Henderson Michael Thomas is listed as Chief Executive Officer of Apogee Therapeutics, Inc. (APGE). Henderson Michael Thomas reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 3.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| APGEApogee Therapeutics, Inc. | Chief Executive Officer | 4 | Sep 3 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| APGEApogee Therapeutics, Inc. | Sep 3 | Sep 3 | D | 920,941 | not reported | not reported | not reported | No | Form 4 |
| APGEApogee Therapeutics, Inc. | Sep 3 | Sep 3 | D · derivative | 387,012 | $22.86 | $8,847,094 | not reported | No | Form 4 |
| APGEApogee Therapeutics, Inc. | Sep 3 | Sep 3 | D · derivative | 357,036 | $49.07 | $17,519,757 | not reported | No | Form 4 |
| APGEApogee Therapeutics, Inc. | Sep 3 | Sep 3 | D · derivative | 253,016 | $75.78 | $19,173,552 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.